SCHEMBL5664937

SCHEMBL5664937

CCCN(CC)C(=O)C(N)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 6/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ KCNE1 P15382 1/20 0.51
▸ KCNH2 Q12809 1/20 0.50
▸ KCNJ5 P48544 1/20 0.43
▸ KCNJ3 P48549 1/20 0.43
▸ SCN5A Q14524 1/20 0.43
▸ KCND3 Q9UK17 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C19 P33261 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TSHR P16473 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5664800 0.93 ALDH1A1 (0.48) KCNA5CYP2D6KCNE1KCNH2KCNJ5
SCHEMBL5663585 0.84 KCNA5 (0.51) KCNA5CYP2D6KCNE1KCNH2KCNJ5
SCHEMBL5664573 0.81 ALDH1A1 (0.46) KCNA5CYP2D6KCNE1KCNH2ALDH1A1
SCHEMBL5664615 0.80 KCNA5 (0.46) KCNA5CYP2D6KCNE1KCNH2KCNJ5
SCHEMBL5665187 0.79 ALDH1A1 (0.43) KCNA5CYP2D6KCNE1KCNH2ALDH1A1
SCHEMBL5666578 0.78 KCNA5 (0.44) KCNA5CYP2D6KCNE1KCNH2KCNJ5
SCHEMBL5664992 0.78 SMN1; SMN2 (0.48) CYP2D6ALDH1A1CYP1A2CYP2C19TP53
SCHEMBL5664717 0.72 HPGD (0.51) ALDH1A1CYP1A2CYP2C19MEN1KMT2A
SCHEMBL16204245 0.72 CYP3A4 (0.47) KCNA5KCNH2ALDH1A1CYP1A2CYP2C19
SCHEMBL16151826 0.72 CYP3A4 (0.47) KCNA5KCNH2ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716137-A1 SUBSTITUTED QUINOLINE COMPOUNDS Pfizer Products Incorporated (US) 2006-11-02 — — EP disclosed
WO-2005080373-A1 SUBSTITUTED QUINOLINE COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-09-01 — — WO disclosed
Send feedback